• #1209323
  • 20
  • Intrivo Diagnostics #RCPM-00279-B

Rapid Test Kit On/Go™ Antigen Detection COVID-19 At-Home Rapid Antigen Test Anterior Nasal Swab Sample 232 Boxes per Case / 2 Tests per Box

TEST KIT, COVID-19 ON/GO RAPIDANTIGEN OTC (2/BX 232BX/CS)

Features
  • The on/go™ COVID-19 Antigen Self-Test has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization (EUA): https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
  • Ships with minimum 30 Days Dating
  • The on/go™ COVID-19 Antigen Self-Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2
  • More …
  Log In to Order
or

Product Specifications


Features
  • The on/go™ COVID-19 Antigen Self-Test has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization (EUA): https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
  • Ships with minimum 30 Days Dating
  • The on/go™ COVID-19 Antigen Self-Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2
  • This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older with symptoms of COVID-19 within the first 7 days of symptom onset
  • This test is also authorized for non-prescription home use with adult-collected nasal (nares) swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset
  • Positive results indicate the presence of viral antigens, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status
  • Positive results do not rule out bacterial infection or co-infection with other viruses and the agent detected may not be the definite cause of disease
  • Negative results should be treated as presumptive and confirmation with a molecular assay for patient management, may be performed if necessary; negative results do not rule out SARS-CoV-2 infection, and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
  • Detects the antigen protein of all known major COVID-19 variants of concern (including Delta and Omicron)
  • Material required but not provided: Smartphone: iOS13 or newer / Android 10 or newer, Mobile App (Prior to testing, the user should download the free mobile application, on/go™ App, for iOS or Android smartphones)
More Information

Professionals Also Viewed